Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashkan Emadi

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Leukemia Research|March 5, 2024
Clinical outcomes of patients with acute myeloid leukemia and cardiovascular diseaseGabriela Sanchez-Petitto, Olga G Goloubeva, Jack Masur, et al.
Leukemia & Lymphoma|June 16, 2020
Clustered incidence of adult acute promyelocytic leukemia in the vicinity of BaltimoreAndrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2019
A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic TransplantationKeith W Pratz, Michelle A Rudek, B Douglas Smith, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2016
Hydroxylated Dimeric Naphthoquinones Increase the Generation of Reactive Oxygen Species, Induce Apoptosis of Acute Myeloid Leukemia Cells and Are Not Substrates of the Multidrug Resistance Proteins ABCB1 and ABCG2Rena G Lapidus, Brandon A Carter-Cooper, Mariola Sadowska, et al.
Acta Haematologica|August 27, 2024
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell TransplantationGabriela Sanchez-Petitto, Olga Goloubeva, James Childress, et al.
Blood|October 22, 2024
A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemiaYuchen Liu, Dominique R Bollino, Osman M Bah, et al.
Cardio-Oncology (London, England)|June 19, 2026
A systematic review of artificial intelligence in radiotherapy associated cardiovascular toxicityVivian Salama, Brandon M Godinich, Nathaniel Dunham, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 3, 2021
Pre-Clinical Activity of Amino-Alcohol Dimeric Naphthoquinones as Potential Therapeutics for Acute Myeloid LeukemiaDana Ferraris, Rena Lapidus, Phuc Truong, et al.
Biology|April 3, 2021
<i>FLT3</i>-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk StratificationAndrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Leukemia|November 17, 2020
Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemiaAshkan Emadi, Bandish Kapadia, Dominique Bollino, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Leukemia Research|March 5, 2024
Clinical outcomes of patients with acute myeloid leukemia and cardiovascular diseaseGabriela Sanchez-Petitto, Olga G Goloubeva, Jack Masur, et al.
Leukemia & Lymphoma|June 16, 2020
Clustered incidence of adult acute promyelocytic leukemia in the vicinity of BaltimoreAndrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2019
A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic TransplantationKeith W Pratz, Michelle A Rudek, B Douglas Smith, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2016
Hydroxylated Dimeric Naphthoquinones Increase the Generation of Reactive Oxygen Species, Induce Apoptosis of Acute Myeloid Leukemia Cells and Are Not Substrates of the Multidrug Resistance Proteins ABCB1 and ABCG2Rena G Lapidus, Brandon A Carter-Cooper, Mariola Sadowska, et al.
Acta Haematologica|August 27, 2024
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell TransplantationGabriela Sanchez-Petitto, Olga Goloubeva, James Childress, et al.
Blood|October 22, 2024
A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemiaYuchen Liu, Dominique R Bollino, Osman M Bah, et al.
Cardio-Oncology (London, England)|June 19, 2026
A systematic review of artificial intelligence in radiotherapy associated cardiovascular toxicityVivian Salama, Brandon M Godinich, Nathaniel Dunham, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 3, 2021
Pre-Clinical Activity of Amino-Alcohol Dimeric Naphthoquinones as Potential Therapeutics for Acute Myeloid LeukemiaDana Ferraris, Rena Lapidus, Phuc Truong, et al.
Biology|April 3, 2021
<i>FLT3</i>-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk StratificationAndrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Leukemia|November 17, 2020
Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemiaAshkan Emadi, Bandish Kapadia, Dominique Bollino, et al.
Pageof 12